Dissolution of omeprazole from delayed-release solid oral dosage forms

Drug Development and Industrial Pharmacy

Volumn 26, Issue 7, 2000, Pages 785-790

  Farinha, A ^a   Bica, A ^a   Martins, J M ^a   Pais, J P ^a  

^a Laboratorio de Estudos Farmaceuticos   (Portugal)

Author keywords

Enteric coated products; In vitro dissolution; Omeprazole

Indexed keywords

OMEPRAZOLE;

ARTICLE; DELAYED RELEASE FORMULATION; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG QUALITY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ENZYME ACTIVITY; PH; STOMACH PARIETAL CELL;

EID: 0034044281     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101300     Document Type: Article

References (9)

1. J. G. Hardman, P. B. Molinoff, and A. G. Gilman, Goodman and Gilman's Pharmacological Basis of Therapeutics. McGraw-Hill Interamericana Editores, S.A., Mexico, 1996, p. 667.
2. S. V. Dighe, in Bio-International: Bioavailability, Bioequivalence and Pharmacokinetics (K. K. Midha and H. H. Blume, Eds.), Medpharm Scientific, Stuttgart, 1993, pp. 247-255.
3. U.S. Pharmacopeial Convention, The United States Pharmacopeia, 23rd rev., Author, Rockville, MD, 1995.
4. Farmacopeia Portuguesa VI, Imprensa Nacional Casa da Moeda, Lisbon, 1997.
5. British Pharmacopoeia, Her Majesty's Stationery Office, London, 1998.
6. European Pharmacopoceia, 3rd ed., Council of Europe, Strasbourg, 1997.
7. FIP (Féderation Internationale Pharmaceutique), Guidelines for Dissolution Testing of Oral Products, 1995.
8. K. Lehman, Acta Pharm., 93, 55-74 (1984).
9. A. G. Davidson and A. McCallum, Drug Dev. Ind. Pharm., 22, 1173-1185 (1996).